In this context we decided to explore the clinical impact of ENDOG in CLL as a model of B-cell neoplasm in which the PI3K-AKT axis is constitutively activated and required for cell survival and proliferation [18]. The gene discussed is AKT1; the disease is B-cell chronic lymphocytic leukemia.